Day: September 20, 2022

The Campus will be Comprised of an Ambulatory Surgery Center and Multiple Medical Facilities GLEN COVE, N.Y., Sept. 20, 2022 (GLOBE NEWSWIRE) — Healthcare Solutions Holdings (OTCPK: HSMD), a vertically-integrated health care system, today announced $85,000,000 of committed capital for the development and construction of a new medical campus in Sealy, TX.  The campus, when completed, will contain a multi-specialty Ambulatory Surgery Center, a medical office building, a second office building with clinical space and two Advance Care Medical complexes. This announcement is the culmination of a signed definitive agreement with Houston-based internal medicine specialist Dr. Kannappan Krishnaswamy, who has also joined the company as the Medical Director of the Houston, TX region. HSMD’s management team is currently working to identify strategic locations...

Roflumilast cream showed higher efficacy compared to vehicle in both Phase 3 studies on the primary efficacy endpoint of Investigator Global Assessment (IGA) success, with 40% of roflumilast cream treated patients achieving IGA success at eight weeks Roflumilast cream also demonstrated statistically significant improvements over vehicle in key secondary endpoints with ~70% of patients achieving Intertriginous-IGA success and ~40% of patients achieving PASI-75 at eight weeks Improvement in itch occurred as early as two weeks and improved consistently through week eight Once-daily ZORYVE™(roflumilast) is approved for topical use in adults and adolescents with plaque psoriasis, including intertriginous psoriasis, regardless of disease severityWESTLAKE VILLAGE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc....

THIS NEWS RELEASE IS NOT FOR DISTRIBUTIONIN THE UNITED STATES OR TO U.S. NEWS AGENCIES HONG KONG, Sept. 20, 2022 (GLOBE NEWSWIRE) — Century Global Commodities Corporation (“Century” or the “Company”) is pleased to announce the results of the 2022 Annual General Meeting of shareholders that was held on September 20, 2022 in Hong Kong, China. The Company is pleased to report that, as in prior years, a very high shareholder response was achieved, with 88.75% of Century’s outstanding shares having been voted at the meeting.   At that meeting, the shareholders:set the size of the Board of Directors at nine members; elected the Board of Directors; and re-appointed PricewaterhouseCoopers LLP as the Company’s auditors for the upcoming year.Number of Directors The number of directors of the Company for the ensuing year was confirmed...

CARLSBAD, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be participating in the Lytham Partners Fall 2022 Investor Conference, taking place virtually on September 28-29, 2022. During the event, the company will be participating in a webcasted presentation discussion and conducting 1×1 virtual investor meetings. The Company’s webcast presentation will be a Panel Discussion hosted by Trent Northcutt, President and CEO and Krissy Ramey, National Director of Clinical Education of Aurora Spine. The discussion is titled: Simplifying the Complex – A Panel Discussion with Doctors that use Aurora Products, and will be available...

Infill and extension exploration drill program at La Loutre Graphite Property Beat ExpectationsEV Zone Drill Map 10%+ High Grade Area at EV Zone identifiedVancouver, BC, Sept. 20, 2022 (GLOBE NEWSWIRE) — Montreal, Quebec – September 20, 2022 – Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko Metals” or the “Company”) is pleased to announce the second round of analytical results from the infill and extension exploration drill program at its wholly-owned La Loutre Graphite property, located approximately 180 kilometres northwest of Montréal in the Laurentian region of Québec. The La Loutre graphite project site is located within the Kitigan Zibi Anishinabeg (KZA) First Nations territory. The drilling was supervised by Québec-based, independent geological consultant Breakaway Exploration Management Inc. and was operated under...

–6th approved indication of toripalimab in China, bringing more treatment options to patients with advanced NSCLC SHANGHAI, China, Sept. 20, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the China National Medical Products Administration (“NMPA”) has approved the supplemental new drug application (“sNDA”) for toripalimab in combination with pemetrexed and platinum as the first-line treatment in EGFR mutation-negative and ALK mutation-negative, unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer (“NSCLC”). This is the sixth indication approved for toripalimab in China and...